HitIQ Issues New Shares Under Disclosure Exemption, Confirms Regulatory Compliance
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from HitIQ Limited ( (AU:HIQ) ) is now available.
HitIQ Limited has issued 2,511,994 fully paid ordinary shares on 6 March 2026 and has confirmed that this issuance was conducted without a prospectus or product disclosure statement under the exemption provisions of the Corporations Act. The company states it is in compliance with its financial reporting and continuous disclosure obligations and that there is currently no excluded information that would need to be disclosed to the market, signalling that the share issue is being carried out within the existing regulatory framework.
The notice serves primarily to preserve the ability for the new shares to be traded without further disclosure, reinforcing transparency around the capital raising process for existing and potential investors. While the announcement does not detail the purpose or terms of the share issue, it underscores HitIQ’s intent to adhere to statutory disclosure standards, which is relevant for shareholders assessing regulatory risk and governance practices.
The most recent analyst rating on (AU:HIQ) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on HitIQ Limited stock, see the AU:HIQ Stock Forecast page.
More about HitIQ Limited
HitIQ Limited is an ASX-listed company operating in the technology sector, although this announcement provides no detail on its specific products, services or market focus. It is a disclosing entity under the Australian Corporations Act and is subject to ongoing financial reporting and continuous disclosure obligations.
Average Trading Volume: 576,599
Technical Sentiment Signal: Sell
Current Market Cap: A$10.09M
See more insights into HIQ stock on TipRanks’ Stock Analysis page.